Back to search results

CBTi for Insomnia in Type 1 Diabetes

This study is exploring if a therapy called Sleep Quality Improvement Therapy (Cognitive Behavioral Therapy for Insomnia, or CBTi) can help people with Type 1 Diabetes who also have trouble sleeping. Researchers want to see if improving sleep can lead to better blood sugar control, improved mood, and less fatigue. You would be comparing Sleep Quality Improvement Therapy to a 'Healthy Living' program. To join, you need to be 18-65 years old, have Type 1 Diabetes for at least a year, use a continuous glucose monitor, and have poor sleep. The study aims to enroll 15 participants, but its current status is unclear.

Study design
This is an interventional study comparing two behavioral interventions. It plans to enroll 15 participants.
What's involved
Participants will attend 3 office visits. If in the Sleep Quality Improvement Therapy group, you will have 8 virtual therapy sessions over 12 weeks. If in the Healthy Living group, you will receive weekly health education emails and brief coaching calls.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint, acceptability, is measured from enrollment to the end of the intervention (12 weeks).

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07091318

CBTi for the Treatment of Insomnia in Type 1 Diabetes

Recruiting
EARLY_PHASE1Ages 18–65InterventionalTreatment
University of Illinois at Chicago
~15 participants
Updated 2026-01-22 on ClinicalTrials.gov
What's tested:Sleep quality improvement therapyHealthy Living

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Acceptability
Measured over From enrollment to the end of the intervention (12 weeks)

Conditions

Diabetes Mellitus Type 1
Insomnia

Explore related trials

InsomniaType 1 Diabetes Mellitus

Where it's being run

1 sites across 1 states
Illinois1

Who to contact

Jennifer Duffecy, PhD
[email protected]
312-413-1225
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Between 18 to 65 years old
Have been diagnosed with Type 1 Diabetes for at least a year
Use a continuous glucose monitor
Have poor sleep quality
Able to attend 3 office visits

Exclusion

Currently or planning pregnancy or breast feeding
Employed with a rotating or night shift
Are at a high risk for obstructive sleep apnea
Non-English speaking (unable to participate in therapy or questionnaire).
Take medications for sleep
moderately severe to severe depression
Have a significant medical history that includes conditions like heart failure, cirrhosis, COPD, diseases requiring oxygen, active treatment for cancer or psychiatric problems, history of stroke with neurological deficits, cognitive impairment, kidney failure that requires dialysis, illicit drug use, use of ADHD stimulant medications.

What this trial measures

  • AcceptabilityFrom enrollment to the end of the intervention (12 weeks)

    Will be measured via the Acceptability of Intervention Measure (AIM) at the end of the interventions. AIM is measured through 4 questions on a scale of 1-5 resulting in scores from 4 to 20 points. The higher the score the higher the acceptability.